A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT05730036 · RECRUITING
Trial details
- NCT number
- NCT05730036
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-18
- Primary completion
- 2033-04-19
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.